Considered and Approved the Audited Financial Results for the Financial Year ended 31st March, 2026.

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionExceptional itemResults View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.0%Reaction day

₹1119.00

prior close

₹1048.30

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%-3.6% vs market

Pharmaceuticals peers, median of 160sector-0.1%-3.9% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Smallcap 250 and 3.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-5.2

10m

-5.6

15m

-6.8

30m

-8.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.0-0.4-3.6-0.1-3.9

Next day

+0.8-1.9+2.7-0.9+1.7

+0.8-0.7+1.5-0.2+1.1

+2.7-0.7+3.3+0.2+2.4

+1.7+0.0+1.7+0.7+1.1

-1.2-0.1-1.1+0.2-1.4

+1.7+1.3+0.4+1.0+0.8

15d

+6.1-0.2+6.3-0.3+6.3

+7.5+3.0+4.5+1.5+6.0

+13.0+7.8+5.2+7.7+5.3

+26.9+9.1+17.8+7.6+19.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences reported strong full-year results for FY26 ending March 2026. Standalone revenue grew 31% to Rs 21,532 million from Rs 16,420 million in FY25, driven by robust performance in contract manufacturing and APIs. Profit after tax nearly doubled to Rs 3,415 million from Rs 1,735 million, representing a 97% PAT growth. Basic EPS improved to Rs 16.27 from Rs 9.00. Finance costs reduced significantly by 53% to Rs 326 million from Rs 700 million, reflecting debt repayment from IPO proceeds. Operating cash flow remained healthy at Rs 4,953 million. The auditors issued an unmodified (clean) opinion with no qualifications. An exceptional item of Rs 80 million (net) was recorded due to Labour Code implementation impacts.

Likely market impact

The results show strong operational performance with revenue and profit growth exceeding expectations. The significant reduction in debt costs and positive cash generation are positive signals for shareholders. The stock appears well-positioned given the clean audit opinion and margin expansion.